On BMS’ Plea, Delhi Court Nixes Hetero’s Dasatinib Application; Directs India’s Drug Controller To Examine Patent Violations

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.